Analyst: China headwinds will dampen Coloplast's first quarter
Covid-19 shutdowns in China have restricted patients’ hospital access, which Danish bank Sydbank says will hurt revenue inflows for the Danish medtech company.
by marketwire, translated by daniel pedersen
Coloplast’s first-quarter report will be a muted start to fiscal 2022/2023, assesses Søren Løntoft Hansen, senior equity analyst at Danish bank Sydbank, the day before the report is slated for release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
